Format

Send to

Choose Destination
Expert Rev Neurother. 2014 Sep;14(9):969-71. doi: 10.1586/14737175.2014.947964.

Can antidepressant medication relieve agitation in Alzheimer's disease?

Author information

1
University of Rochester School of Medicine and Dentistry, 435 East Henrietta Road, Rochester, NY14620, USA.

Abstract

Neuropsychiatric symptoms (NPS) are a major concern in the treatment of Alzheimer's disease. Historically, NPS are difficult to treat effectively due to a high side-effect burden associated with commonly used medications, such as atypical antipsychotics. Non-pharmacological treatment approaches have become the first line option. However, when such treatment fails, pharmacological options are often used. Thus, a push toward finding safer alternative pharmacological treatments has occurred. Antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) have shown promise in clinical trials for alleviating the burden of NPS. Lower overall agitation and caregiver stress has been reported to correlate to treatment with the SSRI citalopram. However, certain side effects of citalopram, such as QTc interval prolongation and increased cognitive decline, carry clinical concern and should be weighed when prescribing their use.

KEYWORDS:

Alzheimer’s disease; agitation; antidepressants; citalopram; neuropsychiatric symptoms; selective serotonin reuptake inhibitors; treatment

PMID:
25148535
DOI:
10.1586/14737175.2014.947964
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center